Helicobacter Pylori Eradication Reduces Gastric Cancer Risk and Mortality
The following is a summary of “Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive...
Read MoreJan 17, 2025
The following is a summary of “Eradication Therapy to Prevent Gastric Cancer in H. pylori-positive...
Read MoreJan 17, 2025
THURSDAY, Jan. 16, 2025 (HealthDay News) — For patients with unresectable, nonmetastatic...
Read MoreJan 17, 2025
THURSDAY, Jan. 16, 2025 (HealthDay News) — Per- and polyfluoroalkyl substances (PFAS) in...
Read MoreJan 17, 2025
THURSDAY, Jan. 16, 2025 (HealthDay News) — For patients with human epidermal growth factor...
Read MoreJan 17, 2025
THURSDAY, Jan. 16, 2025 (HealthDay News) — Cancer mortality is continuing to decline, but...
Read MoreJan 16, 2025
The following is a summary of “Introducing Neoadjuvant Immunotherapy for Colorectal Cancer:...
Read MoreJan 16, 2025
WEDNESDAY, Jan. 15, 2025 (HealthDay News) — Tobacco-associated trachea, bronchus, and lung...
Read MoreJan 16, 2025
WEDNESDAY, Jan. 15, 2025 (HealthDay News) — A machine learning model can make accurate...
Read MoreJan 15, 2025
More frequent follow-up after curative surgery did not significantly reduce 10-year mortality rates in patients with stage II and stage III colorectal cancer.
Read MoreJan 15, 2025
The following is a summary of “Global status and attributable risk factors of breast, cervical,...
Read MoreJan 14, 2025
MONDAY, Jan. 13, 2025 (HealthDay News) — Gastric cancer (GC) is a considerable health...
Read MoreJan 14, 2025
MONDAY, Jan. 13, 2025 (HealthDay News) — Obesity at cancer diagnosis is associated with...
Read MoreJan 14, 2025
MONDAY, Jan. 13, 2025 (HealthDay News) — Differences in distance to lung cancer screening...
Read MoreJan 13, 2025
The following is a summary of “Management, biomarkers and prognosis in people developing...
Read MoreJan 13, 2025
Prostate cancer (PCa) ranks as the second most common disease among men and the fourth most prevalent cancer worldwide. Enhanced glycolysis and excessive lactate secretion are recognized as critical factors driving the...
Read MoreJan 13, 2025
Immunotherapy is improving the survival of patients with metastatic non-small cell lung cancer (NSCLC), yet reliable biomarkers are needed to identify responders prospectively and optimize patient care. In this study, we explore...
Read MoreJan 13, 2025
Recently, it has been realized that immune processes participate in the pathogenesis of human cancers. A large number of genetic polymorphisms in immune-related genes have been extensively examined for their roles in the...
Read MoreJan 13, 2025
To evaluate the prognostic significance of changes in pre- and post-neoadjuvant chemotherapy (NACT) Ki67 in patients with primary invasive triple-negative breast cancer (TNBC).Population-based registry data were retrieved for...
Read MoreJan 13, 2025
Routine screening for patient-reported outcomes may improve access to supportive care services among long-term metastatic breast cancer survivors.
Read MoreJan 10, 2025
The following is a summary of “Lenvatinib and immune-checkpoint inhibitors in hepatocellular...
Read MoreSed vitae nulla id ipsum molestie scelerisque vitae vitae ligula. Fusce a massa tortor.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.